International Quality Medicines – Generic & Biosimilar

In an effort to improve Vietnamese patients’ access to quality medicines, the International Quality Medicines (IQMED) – Generic & Biosimilar, former International Quality Generics (IQGx) Sector Committee was established in October 2016 under EuroCham's Healthcare Forum, raising the total number of Sector Committees under EuroCham to 16 and promising to become an active partner for key healthcare stakeholders.
 
With the aim of pooling viewpoints and superior practices towards providing solutions for an affordable, high-quality and sustainable supply source for branded generic drugs in Vietnam, IQMED – Generic & Biosimilar Sector Committee has created a platform where issues and solutions can be discussed among like-minded business professionals in the industry.

The IQMED – Generics & Biosimilar Sector Committee also contributes to the annual EuroCham Whitebook, focusing on specific recommendations to the Vietnamese Government towards an ever-improving business environment for the healthcare industry and helping patients get better access to affordable and high quality pharmaceutical products in the country.

The Sector Committee is currently chaired by Mr. Stephane Langevin from Baxter Vietnam. The IQMED – Generic & Biosimilar Sector Committee is in the process of extending its members, as well as discussing priority topics for the group’s future internal work, activities and projects.

The activities of the EuroCham IQMED – Generics & Biosimilar Sector Committee, guided by a strong commitment to their common mission, focus on a baseline of key interests: delivering an affordable, high quality, sustainable supply of trusted branded generic medicines and services to Vietnamese people; policy advocacy and collaboration with key healthcare stakeholders such as the Government, providers and payers in Vietnam, towards building efficient legal frameworks and implementation platforms.